ℹ️
🇬🇧
Search
Search for publications relevant for "Cisplatin-induced"
Cisplatin-induced
Publication
Class
Person
Publication
Programmes
publication
Cisplatin-induced apoptosis in cultures of human Schwann cells
2006 |
First Faculty of Medicine, Third Faculty of Medicine
publication
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
2021 |
Second Faculty of Medicine
publication
Effect of two different cytoprotectives, ethiofos and β-NGF, on cisplatin-induced toxicity in Schwann cell cultures; a preliminary study
2004 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Cisplatin induced of GGT activity, protein content and GFAP in glioma cells in culture
Publication without faculty affiliation
publication
Cisplatin induced gamma-glutamyltransferase up-regulation, hypertrophy and differentiation in astrocytic glioma cells in culture
2003 |
First Faculty of Medicine
publication
Cisplatin induced gamma-glutamyltransferase up-regulation, hypertrophy and differentiation in astrocytic glioma cells in culture
2003 |
Faculty of Physical Education and Sport
publication
Cisplatin-induced DNA double-strand breaks promote meiotic chromosome synapsis in PRDM9-controlled mouse hybrid sterility
2018 |
Faculty of Science
publication
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study
2020 |
Second Faculty of Medicine
publication
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study
2020 |
Second Faculty of Medicine
publication
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset
2020 |
Second Faculty of Medicine
publication
Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle
2014 |
Faculty of Science
publication
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
2019 |
Second Faculty of Medicine